PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

por Duell, Johannes, Abrisqueta, Pau, Dreyling, Martin, Gaidano, Gianluca, Barca, Eva González, Jurczak, Wojciech, Liberati, Anna Marina, Maddocks, Kami, Menne, Tobias, Nagy, Zsolt, Tournilhac, Olivier, Bakuli, Abhishek, Amin, Aasim, Gurbanov, Konstantin, Salles, Gilles
Publicado 2023

P1138: FIVE-YEAR EFFICACY AND SAFETY OF TAFASITAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY DLBCL: FINAL RESULTS FROM THE PHASE II L-MIND STUDY

por Duell, Johannes, Abrisqueta, Pau, Andre, Marc, Augustin, Marinela, Gaidano, Gianluca, González Barca, Eva, Jurczak, Wojciech, Kalakonda, Nagesh, Marina Liberati, Anna, Maddocks, Kami, Menne, Tobias, Nagy, Zsolt, Tournilhac, Olivier, Bakuli, Abhishek, Amin, Aasim, Gurbanov, Konstantin, Salles, Gilles
Publicado 2023